Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Nurix Therapeutics Inc (NRIX)

Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Trader at NYSE by Orhan Akkurt via Shutterstock
Stocks Rally as Buyers Return After AI-Led Selloff Barchart - Mon Jun 8, 10:20AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +1.01%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.39%. June E-mini S&P futures (ESM26...

MSTR : 127.53 (+5.89%)
MPC : 264.99 (+1.14%)
SNDK : 1,626.18 (+4.29%)
ADI : 403.00 (+0.40%)
GLXY : 30.39 (+20.88%)
SLB : 56.44 (+2.86%)
COIN : 162.06 (+6.34%)
CIEN : 462.01 (-5.37%)
FANG : 198.10 (+2.84%)
STX : 872.67 (+2.97%)
WDC : 522.94 (+2.19%)
AMD : 488.81 (+4.81%)
New York Stock Exchange during sunrise by Deberarr via iStock
Stocks Push Higher as Chipmakers and AI Companies Rebound Barchart - Mon Jun 8, 8:58AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.59%. June E-mini S&P futures (ESM26...

MSTR : 127.53 (+5.89%)
AMAT : 489.03 (+7.95%)
AVGO : 395.32 (+2.49%)
SNDK : 1,626.18 (+4.29%)
ADI : 403.00 (+0.40%)
GLXY : 30.39 (+20.88%)
WIX : 48.55 (-7.33%)
$IUXX : 29,399.26 (+1.53%)
COIN : 162.06 (+6.34%)
ZNU26 : 108-315 (-0.09%)
CIEN : 462.01 (-5.37%)
ESM26 : 7,417.25 (+0.23%)
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology GlobeNewswire - Mon Jun 8, 12:00AM CDT

Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted therapies and global clinical and commercialization footprint Robust...

NRIX : 15.46 (+5.60%)
RHHBY : 50.5190 (-1.87%)
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting GlobeNewswire - Thu May 14, 3:05PM CDT

In preclinical studies of CSU, Bexobrutideg demonstrates potent BTK degradation across key immune cell types and enhanced suppression of FcεRI-driven pathology versus remibrutinib In healthy volunteers,...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Wed May 13, 6:00AM CDT

BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress GlobeNewswire - Tue May 12, 3:05PM CDT

BRISBANE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 GlobeNewswire - Wed Apr 22, 6:00AM CDT

Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programs Presentations reinforce potential of degraders to overcome limitations of inhibitors and expand therapeutic...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update GlobeNewswire - Wed Apr 8, 5:00AM CDT

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306 bexobrutideg...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics to Participate in Upcoming Investor Conference GlobeNewswire - Tue Apr 7, 6:00AM CDT

BRISBANE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...

NRIX : 15.46 (+5.60%)
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting GlobeNewswire - Mon Mar 23, 3:05PM CDT

BRISBANE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...

NRIX : 15.46 (+5.60%)

Barchart Exclusives

MRVL Stock Alert: Marvell Technologies to Join S&P 500 Barchart - 1 minute ago
Marvell shares rally on news they will replace Pool Corporation on the S&P 500 index later this month. Here’s what makes MRVL stock worth owning at a premium valuation today. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.